{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:30:44Z","timestamp":1789165844019,"version":"build-2803163510"},"reference-count":80,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:p>There is consensus in the scientific literature that the opioid agonist medications methadone and buprenorphine are the most effective treatments for opioid use disorder. Despite increasing opioid overdose deaths in the United States, these medications remain substantially underutilized. For no other medical conditions for which an effective treatment exists is that treatment used so infrequently. In this commentary, we discuss the potential role of stigma in the underutilization of these opioid agonist medications for addiction treatment. We outline stigma toward medications for addiction treatment and suggest that structural and policy barriers to methadone and buprenorphine may contribute to this stigma. We offer pragmatic public health solutions to reduce stigma and expand access to these effective treatments.<\/jats:p>","DOI":"10.1080\/08897077.2019.1640833","type":"journal-article","created":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T16:19:49Z","timestamp":1569341989000},"page":"459-465","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":75,"title":["Underutilization of Medications to Treat Opioid Use Disorder: What Role Does Stigma Play?"],"prefix":"10.1177","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6321-2436","authenticated-orcid":false,"given":"Bennett","family":"Allen","sequence":"first","affiliation":[{"name":"New York City Department of Health and Mental Hygiene, Bureau of Alcohol and Drug Use Prevention, Care, and Treatment Queens, Queens, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1951-4151","authenticated-orcid":false,"given":"Michelle L.","family":"Nolan","sequence":"additional","affiliation":[{"name":"New York City Department of Health and Mental Hygiene, Bureau of Alcohol and Drug Use Prevention, Care, and Treatment Queens, Queens, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Paone","sequence":"additional","affiliation":[{"name":"New York City Department of Health and Mental Hygiene, Bureau of Alcohol and Drug Use Prevention, Care, and Treatment Queens, Queens, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2019,10,1]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6450a3"},{"issue":"19","key":"e_1_3_4_3_2","first-page":"1","article-title":"Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas \u2013 United States","volume":"66","author":"Mack KA","year":"2017","unstructured":"Mack KA, , Jones CM, , Ballesteros MF. Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas \u2013 United States. MMWR Morb Mortal Wkly Rep. 2017;66(19):1\u201312.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_4_4_2","unstructured":"Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality. Treatment Episode Data Set (TEDS): 2005\u20132015. National Admissions to Substance Abuse Treatment Services. BHSIS Series S-91 HHS Publication No. (SMA) 17-5037. Rockville MD: Substance Abuse and Mental Health Services Administration; 2017."},{"key":"e_1_3_4_5_2","volume-title":"National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use","author":"American Society of Addiction Medicine","year":"2015","unstructured":"American Society of Addiction Medicine. National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. Chevy Chase, MD: ASAM; 2015."},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.22.1936"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/M17-3107"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2012.694598"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-018-5982-8"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7396.959"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170958"},{"key":"e_1_3_4_13_2","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","author":"Mattick RP","year":"2003","unstructured":"Mattick RP, , Breen C, , Kimber J, , Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2003;(2):CD002209.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32812-X"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2017.0890"},{"key":"e_1_3_4_16_2","unstructured":"New York City Department of Health and Mental Hygiene. Unpublished data New York NY; 2018."},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-27839-1_3"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.2307\/2626958"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.07.043"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2016.1187240"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1804059"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30469-9"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/jme.23.1.12"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.soc.27.1.363"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2010.12.005"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.02.019"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.05.010"},{"key":"e_1_3_4_28_2","first-page":"1","article-title":"\u201cDon't judge a book by its cover\u201d","volume":"11","author":"Woo J","year":"2017","unstructured":"Woo J, , Bhalerao A, , Bawor M, . \u201cDon't judge a book by its cover\u201d: a qualitative study of methadone patients\u2019 experiences of stigma. Subst Abuse. 2017;11:1\u201312.","journal-title":"a qualitative study of methadone patients\u2019 experiences of stigma. Subst Abuse"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2017.1385633"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1215\/9780822375180"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.05.010"},{"key":"e_1_3_4_32_2","volume-title":"Judging addicts: drug courts and coercion in the justice system. New York, NY:","author":"Tiger R","year":"2012","unstructured":"Tiger R. Judging addicts: drug courts and coercion in the justice system. New York, NY: New York Univ. Press; 2012."},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1080\/15504263.2013.835165"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.04.004"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2014.07.043"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.3109\/10826084.2015.1126737"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11013-016-9496-5"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2012.301191"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.4172\/2324-9005.1000106"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2016.1187240"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-017-4289-2"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1521-0391.2012.12004.x"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/79.4.571"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11673-017-9784-y"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2017.1363238"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2016.08.002"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2015.1059714"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1159\/000049486"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1080\/15265160903090066"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550490802268835"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2013.0183"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.06.009"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2013.09.006"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550880903028510"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005574918294"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1177\/1363461516660884"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2016.03.028"},{"key":"e_1_3_4_58_2","volume-title":"Buprenorphine and methadone dispensing in New York City. New York, NY: New York City Department of Health and Mental Hygiene: Epi Data Brief (96); November","author":"Tuazon E","year":"2017","unstructured":"Tuazon E, , Kunins H, , Paone D. Buprenorphine and methadone dispensing in New York City. New York, NY: New York City Department of Health and Mental Hygiene: Epi Data Brief (96); November 2017."},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2017.03.028"},{"key":"e_1_3_4_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2017.05.009"},{"key":"e_1_3_4_61_2","first-page":"1","article-title":"Demystifying buprenorphine misuse: has fear of diversion gotten in the way of addressing the opioid crisis?","author":"Doernberg M","year":"2019","unstructured":"Doernberg M, , Krawczyk N, , Agus D, , Fingerhood M. Demystifying buprenorphine misuse: has fear of diversion gotten in the way of addressing the opioid crisis? Subst Abus. 2019;1\u20136.","journal-title":"Subst Abus"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30569-X"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2015.302706"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1080\/07347324.2016.1113103"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000275"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2007.02090.x"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2014.1205"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2015.302664"},{"key":"e_1_3_4_69_2","unstructured":"New York City Department of Health and Mental Hygiene. \u201cLiving Proof\u201d. https:\/\/www1.nyc.gov\/assets\/doh\/downloads\/pdf\/basas\/opioid-living-proof-campaign.pdf. Accessed September 13 2018."},{"key":"e_1_3_4_70_2","volume-title":"Federal Guidelines for Opioid Treatment Programs. HHS Publication No. (SMA) PEP15-FEDGUIDEOTP","author":"Substance Abuse and Mental Health Services Administration","year":"2015","unstructured":"Substance Abuse and Mental Health Services Administration. Federal Guidelines for Opioid Treatment Programs. HHS Publication No. (SMA) PEP15-FEDGUIDEOTP. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2015."},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1177\/0706743717711167"},{"key":"e_1_3_4_72_2","first-page":"143","article-title":"Management of opioid addiction with buprenorphine: French history and current management","volume":"7","author":"Polom\u00e9ni P","year":"2014","unstructured":"Polom\u00e9ni P, , Schwan R. Management of opioid addiction with buprenorphine: French history and current management. Int J Gen Med. 2014;7:143\u2013148.","journal-title":"Int J Gen Med"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2017.01.013"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2015.12.005"},{"key":"e_1_3_4_75_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy573"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1177\/0033354917732333"},{"key":"e_1_3_4_77_2","volume-title":"Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence","author":"World Health Organization","year":"2009","unstructured":"World Health Organization. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. Geneva, Switzerland: World Health Organization; 2009."},{"issue":"5","key":"e_1_3_4_78_2","first-page":"327","article-title":"Mutual mistrust in the medical care of drug users: the keys to the \u201cnarc\u201d cabinet","volume":"17","author":"Merrill JO","year":"2002","unstructured":"Merrill JO, , Rhodes LA, , Deyo RA, , Marlatt GA, , Bradley KA. Mutual mistrust in the medical care of drug users: the keys to the \u201cnarc\u201d cabinet. J Gen Intern Med. 2002;17(5):327\u2013333.","journal-title":"J Gen Intern Med"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2011.640090"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2016.1224314"},{"key":"e_1_3_4_81_2","doi-asserted-by":"publisher","DOI":"10.1080\/09595230601184661"}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2019.1640833","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2019.1640833","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2019.1640833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:45:46Z","timestamp":1780490746000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2019.1640833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1080\/08897077.2019.1640833"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2019.1640833","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}